CZ20011642A3 - Léčivo pro prevenci progrese aterosklerózy u savců - Google Patents

Léčivo pro prevenci progrese aterosklerózy u savců

Info

Publication number
CZ20011642A3
CZ20011642A3 CZ20011642A CZ20011642A CZ20011642A3 CZ 20011642 A3 CZ20011642 A3 CZ 20011642A3 CZ 20011642 A CZ20011642 A CZ 20011642A CZ 20011642 A CZ20011642 A CZ 20011642A CZ 20011642 A3 CZ20011642 A3 CZ 20011642A3
Authority
CZ
Czechia
Prior art keywords
aliquot
progression
mammal
aterosclerosis
mammals
Prior art date
Application number
CZ20011642A
Other languages
English (en)
Inventor
Duncan J. Stewart
Original Assignee
Vasogen Ireland Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/304,262 external-priority patent/US6264646B1/en
Application filed by Vasogen Ireland Limited filed Critical Vasogen Ireland Limited
Publication of CZ20011642A3 publication Critical patent/CZ20011642A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Aggression treatment or altering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electrotherapy Devices (AREA)
CZ20011642A 1998-11-13 1999-11-15 Léčivo pro prevenci progrese aterosklerózy u savců CZ20011642A3 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19023698A 1998-11-13 1998-11-13
US09/304,262 US6264646B1 (en) 1998-11-13 1999-05-06 Method for preventing and reversing atherosclerosis in mammals

Publications (1)

Publication Number Publication Date
CZ20011642A3 true CZ20011642A3 (cs) 2002-06-12

Family

ID=26885899

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011642A CZ20011642A3 (cs) 1998-11-13 1999-11-15 Léčivo pro prevenci progrese aterosklerózy u savců

Country Status (16)

Country Link
EP (1) EP1128837B1 (cs)
JP (1) JP2002529510A (cs)
CN (1) CN1230182C (cs)
AT (1) ATE233093T1 (cs)
AU (1) AU768300B2 (cs)
BR (1) BR9915270A (cs)
CA (1) CA2348599A1 (cs)
CZ (1) CZ20011642A3 (cs)
DE (1) DE69905602T2 (cs)
DK (1) DK1128837T3 (cs)
EA (1) EA003421B1 (cs)
ES (1) ES2192885T3 (cs)
MX (1) MXPA01004801A (cs)
NO (1) NO20012311L (cs)
NZ (1) NZ511467A (cs)
WO (1) WO2000029003A2 (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2271190A1 (en) 1999-05-06 2000-11-06 Vasogen Ireland Limited Improved method for treating mammals with modified mammalian blood
US7125897B1 (en) 1999-09-24 2006-10-24 Vasogen Ireland Limited Combined therapies for atherosclerosis treatment
CA2309417A1 (en) 2000-05-25 2001-11-25 Anthony E. Bolton Apoptotic entities for use in treatment of endothelium dysfunction disorders
WO2005097145A1 (en) * 2004-04-12 2005-10-20 Vasogen Ireland Limited Myocarditis treatment
WO2008000067A1 (en) * 2006-06-26 2008-01-03 Vasogen Ireland Limited Treatment of mild chronic heart failure in human patients
RU2475275C1 (ru) * 2011-08-08 2013-02-20 Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ лечения облитерирующего атеросклероза артерий нижних конечностей
RU2475276C1 (ru) * 2011-08-09 2013-02-20 Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ лечения облитерирующего атеросклероза артерий нижних конечностей
RU2475274C1 (ru) * 2011-08-09 2013-02-20 Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ лечения атеросклероза артерий нижних конечностей

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD249143A3 (de) * 1985-03-20 1987-09-02 Ilmenau Tech Hochschule Vorrichtung zur physiologisch-therapeutisch wirksamen optischen bestrahlung koerpereigenen venenblutes
US5980954A (en) * 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
WO1993015778A1 (en) * 1992-02-07 1993-08-19 Anthony Ernest Bolton Method of inhibiting the aggregation of blood platelets

Also Published As

Publication number Publication date
BR9915270A (pt) 2003-12-30
CA2348599A1 (en) 2000-05-25
ES2192885T3 (es) 2003-10-16
CN1330549A (zh) 2002-01-09
DE69905602T2 (de) 2003-10-09
EP1128837B1 (en) 2003-02-26
DE69905602D1 (de) 2003-04-03
DK1128837T3 (da) 2003-06-16
EA200100543A1 (ru) 2001-10-22
EA003421B1 (ru) 2003-04-24
AU1145000A (en) 2000-06-05
NO20012311D0 (no) 2001-05-10
CN1230182C (zh) 2005-12-07
EP1128837A2 (en) 2001-09-05
WO2000029003A2 (en) 2000-05-25
NZ511467A (en) 2002-12-20
NO20012311L (no) 2001-07-02
MXPA01004801A (es) 2002-09-18
JP2002529510A (ja) 2002-09-10
WO2000029003A3 (en) 2000-08-31
ATE233093T1 (de) 2003-03-15
AU768300B2 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
IL138979A0 (en) Use of cannabinoids as anti-inflammatory agents
CA2400801A1 (en) Treatment of congestive heart failure by pretreated autologous blood
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
ES2192642T3 (es) Producto para el teñido oxidante de fibras de queratina..
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
AU5392001A (en) Taci as an anti-tumor agent
BG106057A (en) Method of enhancing the efficacy of anti-tumour agents
AU6178198A (en) Method of treating a tumor
WO1999012951A8 (en) Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
WO2000029003A3 (en) Method for preventing and reversing atherosclerosis in mammals
MY120527A (en) Disposable absorbent undergarment.
MY111543A (en) Use of il-10 to prevent or treat insulin-dependent diabetes mellitus
AU4779599A (en) Methods of inhibiting (helicobacter pylori)
SE9803079D0 (sv) Sätt och anordning vid värmebehandling av kroppsvävnad
EA199800819A1 (ru) Способ лечения биполярного расстройства
NZ515727A (en) Aminotetralin derivative for the therapy of cardiovascular diseases
AU7500200A (en) Combined therapies for atherosclerosis treatment
UA30521A (uk) Спосіб лікування доброякісної гіперплазії передміхурової залози у поєднанні з хронічним калькульозним простатитом
UA32320A (uk) Спосіб лікування муковісцидозу
MX9701533A (es) Procedimiento para reducir lesiones en tejidos asociadas con isquemia no cardiaca.
UA32153A (uk) Спосіб формування трансплантату для зведення на промежину при черевно-анальних резекціях прямої кишки
EP1163514A4 (en) IN VIVO AND IN VITRO MODEL FOR SKIN PHOTO-AGING AND OXIDATIVE DESTRUCTION
UA43400C2 (uk) Спосіб підсилення рівня електричного сигналу
UA32157A (uk) Спосіб лікування діабетичної ретинопатії
UA32314A (uk) Спосіб лікування некротичного панкреатиту